Paul Denslow is the CEO of Intus Bio, a company he co-founded in 2022 with the goal of making the microbiome — the vast collection of bacteria in each of us — as integral to healthcare as it is to our health. Paul started his career in global banking, working for HSBC and Standard Chartered, where he ultimately ran a regional financial markets business. Paul’s career pivot was prompted by his own personal health journey, which revealed the opportunity that closing the wide gap between science and healthcare represented for improving patient outcomes. Paul is originally from the UK and currently resides in Southern California.